Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis

Condition:   Deep Fibromatosis/Desmoid TumorInterventions:   Drug: Sorafenib Tosylate;   Other: Placebo;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life AssessmentSponsor:   National Cancer Institute (NCI)Recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials